Evidence
Life Sci. 2024 Jan 17:122431. doi: 10.1016/j.lfs.2024.122431. Online ahead of print.
ABSTRACT
Liver disease has become one of the main causes of health issue worldwide. Sirtuin (Sirt) 2 is a nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase, and is expressed in multiple organs including liver, which plays important and complex roles by interacting with various substrates. Physiologically, Sirt2 can improve metabolic homeostasis. Pathologically, Sirt2 can alleviate inflammation, endoplasmic reticulum (ER) stress, promote liver regeneration, maintain iron homeostasis, aggravate fibrogenesis and regulate oxidative stress in liver. In liver diseases, Sirt2 can mitigate fatty liver disease (FLD) including non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD), but aggravate hepatitis B (HBV) and liver ischemia-reperfusion injury (LIRI). The role of Sirt2 in liver cancer and aging-related liver diseases, however, has not been fully elucidated. In this review, these biological processes regulated by Sirt2 in liver are summarized, which aims to update the function of Sirt2 in liver and to explore the potential role of Sirt2 as a therapeutic target for liver diseases.
PMID:38242495 | DOI:10.1016/j.lfs.2024.122431
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
The role of Sirtuin 2 in liver – An extensive and complex biological process
🌐 90 Days
VR Related Evidence Matrix
- Adipose-derived extracellular vesicles - a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Puerarin protects the fatty liver from ischemia-reperfusion injury by regulating the PI3K/AKT signaling pathway
- Inflammatory liver diseases and susceptibility to sepsis
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
- Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
- The role of endoplasmic reticulum stress-related genes in the diagnosis and subtyping of non-alcoholic fatty liver disease
- Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
- Targeted platelet with hydrogen peroxide responsive behavior for non-alcoholic steatohepatitis detection
- Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
- Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- The double roles of T cell-mediated immune response in the progression of MASLD
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Review and expert opinion on MAFLD, oxidative stress and multifunctional management
- Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma
- Chronic liver disease and management with silymarin: an introductory review of a clinical case collection
- Role of the angiopoietin-like protein family in the progression of NAFLD
- Pharmacology of bioactive compounds from plant extracts for improving non-alcoholic fatty liver disease through endoplasmic reticulum stress modulation: A comprehensive review
- Occult liver disease: a multinational perspective
- Mass spectrometry imaging-based metabolomics highlights spatial metabolic alterations in three types of liver injuries
- Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
- Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Metabolic study of iron deposition based on magnetic resonance in patients with nonalcoholic fatty liver disease
- Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- Therapeutic potential of oleanolic acid in liver diseases
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
- Serine protease inhibitor from the muscle larval Trichinella spiralis ameliorates non-alcoholic fatty liver disease in mice via anti-inflammatory properties and gut-liver crosstalk
- Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet
- Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice
- Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation
- Anthocyanin: A Potential Phytochemical Candidate for the Amelioration of Non-Alcoholic Fatty Liver Disease
- Lipid sensing nuclear receptors involved in the pathogenesis of fatty liver disease
- Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome
- Mitochondrial dysfunction: A promising therapeutic target for liver diseases
- Diabetes Mellitus among Patients with Non-alcoholic Fatty Liver Disease Visiting the Outpatient Department of Internal Medicine in a Tertiary Care Centre
- Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review)
- Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
- Interaction between fatty acid oxidation and ethanol metabolism in liver
- The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic target
- Interleukins in liver disease treatment
- (+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease
- Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Compromised very-low density lipoprotein induced polyunsaturated triglyceride accumulation in N-nitrosodiethylamine-induced hepatic steatosis
- Plastic compounds and liver diseases: Whether bisphenol A is the only culprit
- NcRNA Regulated Pyroptosis in Liver Diseases and Traditional Chinese Medicine Intervention: A Narrative Review
Evidence Blueprint
The role of Sirtuin 2 in liver – An extensive and complex biological process
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
The role of Sirtuin 2 in liver – An extensive and complex biological process
🌐 365 Days
VR Related Evidence Matrix
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT/NAD+/SIRT1 axis
- Adipose-derived extracellular vesicles - a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Hormone action and liver disease, a complex interplay
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Nicotinamide N-methyltransferase and liver diseases
- Liver sinusoidal endothelial transcription factors in metabolic homeostasis and disease
- Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease
- Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Transcription factor EB: A potential integrated network regulator in metabolic-associated cardiac injury
- Puerarin protects the fatty liver from ischemia-reperfusion injury by regulating the PI3K/AKT signaling pathway
- Inflammatory liver diseases and susceptibility to sepsis
- The role of N6-methyladenosine methyltransferase RBM15 in non-alcoholic fatty liver disease
- Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
- Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- Fatty liver disease's renaming impacts on drug clinical trials
- Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota
- Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
- Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
- Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease
- Myokines: Crosstalk and Consequences on Liver Physiopathology
- The role of endoplasmic reticulum stress-related genes in the diagnosis and subtyping of non-alcoholic fatty liver disease
- SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review
- Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
- Targeted platelet with hydrogen peroxide responsive behavior for non-alcoholic steatohepatitis detection
- Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery
- Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
- Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome
- Corrected and republished from: Metabolic associated liver disease
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease
- The double roles of T cell-mediated immune response in the progression of MASLD
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Metabolic dysfunction: The silenced connection with fatty liver disease
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Review and expert opinion on MAFLD, oxidative stress and multifunctional management
- Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma
- New Insights into Nutrition and Gut-Liver Axis: A Focus on Non-Alcoholic Fatty Liver Disease
- Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
- Phospholipid metabolism in the liver - Implications for phosphatidylserine in non-alcoholic fatty liver disease
- Alcoholic liver disease - 2023
- Chronic liver disease and management with silymarin: an introductory review of a clinical case collection
- Role of the angiopoietin-like protein family in the progression of NAFLD
- The Prothrombotic Tendency of Metabolic-Associated Fatty Liver Disease
- Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD
- Pharmacology of bioactive compounds from plant extracts for improving non-alcoholic fatty liver disease through endoplasmic reticulum stress modulation: A comprehensive review
- Occult liver disease: a multinational perspective
- Mass spectrometry imaging-based metabolomics highlights spatial metabolic alterations in three types of liver injuries
- Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
- Dissecting the potential role of ferroptosis in liver diseases: an updated review
- Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress
- Research progress of celastrol on the prevention and treatment of metabolic associated fatty liver disease
- Exosomes: Nomenclature, Isolation, and Biological Roles in Liver Diseases
- NLRP3 inflammasome in hepatic diseases: A pharmacological target